Elicera featured in Life Science Sweden's perspective on CAR T-cell therapies

March 1, 2022

Elicera’s work to develop CAR T-cell therapies against solid tumors is highlighted in Life Science Sweden’s perspective section on CAR T-cell therapies in their first edition of 2022 (subscription required).

‍

Download attachment (pdf)https://www.lifesciencesweden.se/article/view/836457/life_science_swedens_international_issue_is_on_its_way< Back to press releases